At Nucletron we believe that our solutions, services and extensive knowledge of precisely targeted radiotherapy can play a vital role in treating cancer successfully.

With 35 years of experience we are the preferred partner in brachytherapy and independent external beam treatment planning for more than 2,500 institutions worldwide. We continue to build on this with 500 dedicated employees, a global presence in more than 100 countries and an ongoing investment in innovation.

What matters to you, matters to us
We know that the clinical effectiveness of brachytherapy continues to make it a preferred treatment for radiotherapy centers across the world. This is precisely why we continue to invest in generating evidence and raising the awareness of brachytherapy.

Targeted solutions, Precise benefits
Through our connections with world leading clinical experts and our commitment to investing over 10% of our revenues into innovation we are able to continuously improve our solutions. Together, this makes brachytherapy both easy to deliver and a sound investment.

More than just technology
Our global network of over 45 application experts provides first class support, training and educational opportunities, whilst connecting you to leading radiotherapy centers and key opinion leaders. All this ensures you can deliver the best care in the world.